Slovak Republic vs Spain: Enforcing contracts: Court structure and proceedings (0-5)
Enforcing contracts: Court structure and proceedings (0-5) over time
- Slovak Republic
- Spain
How they compare
Slovak Republic currently reports 3.5 DB17-20 methodology against 3.5 DB17-20 methodology in Spain, a difference of 0 DB17-20 methodology.
Across all 5 years both countries report, Spain has been ahead every year.
Slovak Republic ranks 68th and Spain ranks 68th of 190 countries.
Frequently asked questions
- Which has higher enforcing contracts: court structure and proceedings (0-5), Slovak Republic or Spain?
- Slovak Republic, at 3.5 DB17-20 methodology against 3.5 DB17-20 methodology in Spain as of 2019.
- What is the difference in enforcing contracts: court structure and proceedings (0-5) between Slovak Republic and Spain?
- 0 DB17-20 methodology, with Slovak Republic ahead.
- How many years of comparable data are there for Slovak Republic and Spain?
- 5 years are reported by both, from 2015 to 2019.
- How do Slovak Republic and Spain rank globally for enforcing contracts: court structure and proceedings (0-5)?
- Slovak Republic ranks 68th and Spain ranks 68th of 190 countries.
- Where does this data come from?
- The World Bank, published as Enforcing contracts: Court structure and proceedings (0-5) (DB17-20 methodology). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The court structure and proceedings evaluates five aspects of the court system: (i) whether a specialized commercial court, division or section is available; (ii) whether a small claims court and/or simplified procedure for small claims is available; (iii) whether pretrial attachment of defendant's movable assets is available; (iv) whether new cases are assigned randomly and through an automated system to judges; and (v) whether a woman’s testimony in court carries the same evidentiary weight as that of a man's. The index is computed based on the methodology in the DB17-20 studies.